These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 21704348

  • 1. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
    Candia R, Riquelme A, Baudrand R, Carvajal CA, Morales M, Solís N, Pizarro M, Escalona A, Carrasco G, Boza C, Pérez G, Padilla O, Cerda J, Fardella CE, Arrese M.
    Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
    [Abstract] [Full Text] [Related]

  • 3. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C.
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [Abstract] [Full Text] [Related]

  • 4. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A, Grino M.
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
    Baudrand R, Carvajal CA, Riquelme A, Morales M, Solis N, Pizarro M, Escalona A, Boza C, Pérez G, Domínguez A, Arrese M, Fardella CE.
    Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
    [Abstract] [Full Text] [Related]

  • 6. The expression of omental 11β-HSD1 is not increased in severely obese women with metabolic syndrome.
    Michalaki M, Kyriazopoulou V, Antonacopoulou A, Koika V, Nikolaou M, Tsoukas A, Kalfarentzos F, Vagenakis AG, Voukelatou G, Papavassiliou AG.
    Obes Facts; 2012 Jan; 5(1):104-11. PubMed ID: 22433622
    [Abstract] [Full Text] [Related]

  • 7. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK, Pedersen SB, Fisker S, Richelsen B.
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [Abstract] [Full Text] [Related]

  • 8. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V, Medina P, Bouwman C, Johnson MC, Godoy J, López T, Iñiguez G.
    Horm Res; 2009 Aug; 71(2):89-93. PubMed ID: 19129713
    [Abstract] [Full Text] [Related]

  • 9. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
    Li X, Lindquist S, Chen R, Myrnäs T, Angsten G, Olsson T, Hernell O.
    Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K, Andres J, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [Abstract] [Full Text] [Related]

  • 11. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB.
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [Abstract] [Full Text] [Related]

  • 12. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T, Honour JW, Conway GS.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [Abstract] [Full Text] [Related]

  • 13. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
    Westerbacka J, Yki-Järvinen H, Vehkavaara S, Häkkinen AM, Andrew R, Wake DJ, Seckl JR, Walker BR.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
    [Abstract] [Full Text] [Related]

  • 14. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, Luft FC, Sharma AM.
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [Abstract] [Full Text] [Related]

  • 15. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
    Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F, Liuzzi A, Di Blasio AM.
    Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
    [Abstract] [Full Text] [Related]

  • 16. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 17. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [Abstract] [Full Text] [Related]

  • 18. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
    Zhu L, Hou M, Sun B, Burén J, Zhang L, Yi J, Hernell O, Li X.
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
    [Abstract] [Full Text] [Related]

  • 19. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
    Muñoz R, Carvajal C, Escalona A, Boza C, Pérez G, Ibáñez L, Fardella C.
    Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
    [Abstract] [Full Text] [Related]

  • 20. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP, Corrigan M, Gathercole L, Taylor A, Hughes B, Gaoatswe G, Manolopoulos K, Hogan AE, O'Connell J, Stewart PM, Tomlinson JW, O'Shea D, Sherlock M.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.